1.00Open1.00Pre Close0 Volume34 Open Interest30.00Strike Price0.00Turnover214.75%IV88.11%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier27DDays to Expiry1.00Extrinsic Value100Contract SizeAmericanOptions Type0.2317Delta0.0318Gamma16.48Leverage Ratio-0.0549Theta0.0021Rho3.82Eff Leverage0.0136Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet